The page is the record's research on the issuer — no analyst, no rating, no view.

# Mereo BioPharma Group plc (NASDAQ: MREO) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Mereo BioPharma Group plc, listed on NASDAQ under ticker MREO, with ISIN US5894921072 and LEI 213800U8JQHIJOS5AS09. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United Kingdom. The issuer is listed and not halted.

## The disclosure read

The record holds 44 filings in the twelve months to 2026-11-08, across 20 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-10-28, 11 days before the record date, and is of type regulatory_filing. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. On 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days across 526 issuers.

## Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

The issuer's investor-relations page names 9 research houses: Baird, BTIG, Cantor Fitzgerald, Jefferies, JP Morgan, Leerink Partners, LifeSci Capital, Needham and Van Lanschot Kempen.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001719714.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/MREO (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.mereobiopharma.com/investors/ (coverage)
- https://mcp.us-cm-kg.ai/record/NASDAQ/MREO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/MREO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp